Viewing Study NCT05509595


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-29 @ 12:37 PM
Study NCT ID: NCT05509595
Status: COMPLETED
Last Update Posted: 2025-01-22
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module